We are developing several high producing stable cell lines for
Biosimilars.

6 Protein therapeutic drugs

4 Antibody therapeutic drugs

Our Three Business Strategies are:

1) To sell or license the cell lines to Pharmaceutical companies

2) To develop cell lines under contractual agreement for Pharmaceutical     
companies

3) To co-develop Biosimilar drugs with other Pharmaceutical companies for
commercialization.

Please contact us for details:
Email: info@hyprocell.com
Phone:(203)-747-1693

We can also develop high producing stable antibody or protein cell lines of
your interest. In addition, we can produce antibody or protein, purify them and
provide the
purified material for your studies.
Hyprocell's Biosimilar High Producing Cell Lines Portfolio
Modular Flowcytometer (MoFlo)
allows the isolation of single
cell from a mixture of cells at a
speed of 70,000 events per sec.